Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-07

Clinical Trial Update: Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis [NA]

View source ↗

Summary

A clinical trial is evaluating the efficacy and safety of Arbidol (umifenovir) for treating allergic rhinitis, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARbidol (umifenovir)

Snippet

Sponsor: Zheng Liu | Conditions: Allergic Rhinitis | NA | Status: RECRUITING